Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.

[1]  G. Limongelli,et al.  Management of Arrhythmias in Heart Failure , 2017, Journal of cardiovascular development and disease.

[2]  G. Limongelli,et al.  Mitochondrial disease and the heart , 2016, Heart.

[3]  J. Bartunek,et al.  Myocarditis in Clinical Practice. , 2016, Mayo Clinic proceedings.

[4]  S. Wung.  Bradyarrhythmias: Clinical Presentation, Diagnosis, and Management. , 2016, Critical care nursing clinics of North America.

[5]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[6]  H. Yoo,et al.  Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes , 2016, Journal of Human Genetics.

[7]  R. Furlan,et al.  Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. , 2016, The Cochrane database of systematic reviews.

[8]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[9]  J. Finsterer,et al.  Sudden cardiac death in neuromuscular disorders. , 2016, International journal of cardiology.

[10]  Roger D. White,et al.  Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2015, Circulation.

[11]  D. Montaigne,et al.  Mitochondrial cardiomyopathy and related arrhythmias. , 2015, Cardiac electrophysiology clinics.

[12]  M. Judson,et al.  Pathophysiology and clinical management of cardiac sarcoidosis , 2015, Nature Reviews Cardiology.

[13]  T. Vera.  Respuesta al ECG de febrero de 2015 , 2015 .

[14]  Álvaro García Ropero,et al.  Cardiac amyloidosis and pacemakers: could devices delay diagnosis? , 2015 .

[15]  Á. A. Navarro,et al.  Amiloidosis cardiaca y marcapasos: ¿los dispositivos podrían retrasar el diagnóstico? , 2015 .

[16]  C. Albert,et al.  Ventricular Tachycardia in Cardiac Sarcoidosis: Characterization of Ventricular Substrate and Outcomes of Catheter Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[17]  M. Boyett,et al.  Biology of the Sinus Node and its Disease. , 2014, Arrhythmia & electrophysiology review.

[18]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[19]  J. Kalman,et al.  Fibrosis, Electrics and Genetics , 2014 .

[20]  Matthew Dare,et al.  Heart Rhythm Society Expert Consensus Statement on Electrophysiology Laboratory Standards: Process, Protocols, Equipment, Personnel, and Safety , 2014, Heart Rhythm.

[21]  A. Prasse,et al.  Sarcoidosis , 2014, The Lancet.

[22]  R. D'Alessandro,et al.  Skeletal muscle involvement in cardiomyopathies , 2013, Journal of Cardiovascular Medicine.

[23]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[24]  J. Daubert,et al.  Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. , 2013, Archives of cardiovascular diseases.

[25]  Y. Pinto,et al.  Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[26]  G. Bonne,et al.  ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.

[27]  S. Barra,et al.  A Review on Advanced Atrioventricular Block in Young or Middle‐Aged Adults , 2012, Pacing and clinical electrophysiology : PACE.

[28]  W. Groh.  Arrhythmias in the muscular dystrophies. , 2012, Heart rhythm.

[29]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. , 2012, Circulation.

[30]  D. Chemla,et al.  Prophylactic pacemaker implantation in familial amyloid polyneuropathy. , 2012, Heart rhythm.

[31]  G. Breithardt,et al.  Bradyarrhythmias and conduction blocks. , 2012, Revista espanola de cardiologia.

[32]  J. Finsterer,et al.  Arrhythmia-related workup in hereditary myopathies. , 2012, Journal of electrocardiology.

[33]  G. Breithardt,et al.  Bradyarrhythmias and conduction blocks. , 2012 .

[34]  U. Sechtem,et al.  Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy , 2012, Heart.

[35]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[36]  P. Elliott,et al.  Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  M. Boyett,et al.  Ageing‐dependent remodelling of ion channel and Ca2+ clock genes underlying sino‐atrial node pacemaking , 2011, Experimental physiology.

[38]  M. Kupari,et al.  Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults , 2011, Circulation. Arrhythmia and electrophysiology.

[39]  Y. Pinto,et al.  Hereditary muscular dystrophies and the heart , 2010, Neuromuscular Disorders.

[40]  F. Salvi,et al.  Transthyretin-related amyloidoses and the heart: a clinical overview , 2010, Nature Reviews Cardiology.

[41]  J. Zamorano,et al.  Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. , 2007, European heart journal.

[42]  Robert H. Anderson,et al.  New insights into pacemaker activity: promoting understanding of sick sinus syndrome. , 2007, Circulation.

[43]  S. Ellard,et al.  The laminopathies: a clinical review , 2006, Clinical genetics.

[44]  F. Tesson,et al.  Lamin A/C and cardiac diseases , 2006, Current opinion in cardiology.

[45]  F. Prinzen,et al.  A new paradigm for physiologic ventricular pacing. , 2006, Journal of the American College of Cardiology.

[46]  R. Falk.  Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[47]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[48]  D. Garboczi,et al.  The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. , 2004, Journal of molecular biology.

[49]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[50]  T. Cohen,et al.  Complete heart block due to lyme carditis. , 2003, The Journal of invasive cardiology.

[51]  L. Crown,et al.  Diagnosis and treatment of sick sinus syndrome. , 2003, American family physician.

[52]  L. Bindoff.  Mitochondria and the heart. , 2003, European heart journal.

[53]  M. Silka,et al.  The Clinical Course of Acquired Complete Heart Block in Children with Acute Myocarditis , 2003, Pediatric Cardiology.

[54]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[55]  M. Brignole,et al.  Sick sinus syndrome. , 2002, Clinics in geriatric medicine.

[56]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[57]  W. Stevenson,et al.  Management of Arrhythmias in Heart Failure , 2002, Congestive heart failure.

[58]  P. Vardas,et al.  Sinus Pacemaker Function after Cardioversion of Chronic Atrial Fibrillation: Is Sinus Node Remodeling Related with Recurrence? , 2001, Journal of cardiovascular electrophysiology.

[59]  A. Natale,et al.  Congestive Heart Failure Treatment: The Pacing Approach , 2001, Heart Failure Reviews.

[60]  Joanne Eastaugh,et al.  The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.

[61]  Mangrum Jm,et al.  The Evaluation and Management of Bradycardia , 2000 .

[62]  D. Hayes,et al.  Symptomatic conduction system disease in cardiac amyloidosis. , 1997, The American journal of cardiology.

[63]  R. Salo,et al.  Acute Hemodynamic Improvement by Pacing in Patients with Severe Congestive Heart Failure , 1997, Pacing and clinical electrophysiology : PACE.

[64]  Camm Aj,et al.  Sinus node disease. Current concepts in diagnosis and therapy. , 1992 .

[65]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[66]  W. Stanage,et al.  Birth certificate data: how reliable? , 1984, South Dakota journal of medicine.

[67]  C. B. Mullins,et al.  Prognoses and management of venticular conduction blocks in acute myocardial infarction. , 1976, Modern concepts of cardiovascular disease.

[68]  R. O'rourke.  Clinical cardiology: the stokes-adams syndrome-definition and etiology; mechanisms and treatment. , 1972, California medicine.

[69]  K. Smith,et al.  Aetiology of Complete Heart-block , 1963, Lancet.

[70]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[71]  R. D'Alessandro,et al.  Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. , 2012, Future cardiology.

[72]  P. Elliott,et al.  Anderson-Fabry disease and the heart. , 2010, Progress in cardiovascular diseases.

[73]  L. Cooper,et al.  Cardiac sarcoidosis. , 2009, American heart journal.

[74]  D. Hayes,et al.  Second-degree atrioventricular block: a reappraisal. , 2001, Mayo Clinic proceedings.

[75]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[76]  B. Waller,et al.  Anatomy, histology, and pathology of the cardiac conduction system. III , 1993 .

[77]  J Ross,et al.  Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. , 1988, Journal of the American College of Cardiology.

[78]  D. Durrer,et al.  Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. , 1980, American heart journal.